Skip to main content

BELBUCA® – A NEW TREATMENT OPTION FOR CANADIANS LIVING WITH CHRONIC PAIN – NOW AVAILABLE IN CANADA

Published on - January 30, 2018

Pickering, ON (Canada) (January 30, 2018): Purdue Pharma (Canada) and BioDelivery Sciences International Inc. (BDSI)…

Read More >

Purdue Pharma (Canada): Beyond the Products – Message from David Pidduck, President & CEO, Purdue Pharma (Canada)

Published on - December 21, 2017

If you’ve spent some time reading through the Purdue Pharma (Canada) website, you will know…

Read More >

NEW SINGLE CAPSULE TREATMENT AKYNZEO™ NOW AVAILABLE FOR THE PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING IN CANADA

Published on - November 28, 2017

Pickering, ON (Canada) (November 28, 2017): Purdue Pharma (Canada) announce today that AKYNZEO™ (netupitant/palonosetron hydrochloride)…

Read More >

National Pain Awareness Week – Message from Dr. Tom Koutsavlis, Vice-President, Research & Development, Purdue Pharma (Canada)

Published on - November 6, 2017

We know that chronic pain can have devastating effects on a patient’s quality of life….

Read More >

David A. Pidduck Appointed President and CEO of Purdue Pharma (Canada)

Published on - September 25, 2017

Pickering, Ontario, September 25, 2017/CNW/ — David A. Pidduck has been appointed as President and…

Read More >

Klaria signs exclusive development, license and supply agreement with Purdue Pharma (Canada) for acute treatment of opioid overdose (KL-00514)

Published on - August 9, 2017

Uppsala, Sweden and Pickering, Canada, August 9, 2017/CNW/ – Klaria AB (Klaria) (Parent Company, Klaria…

Read More >

BIODELIVERY SCIENCES SIGNS EXCLUSIVE AGREEMENT WITH PURDUE PHARMA (CANADA) FOR THE LICENSING AND DISTRIBUTION RIGHTS OF BELBUCA® IN CANADA

Published on - July 12, 2017

Raleigh, North Carolina (USA) and Pickering, Ontario (CANADA), July 12, 2017/CNW/: Today, BioDelivery Sciences International…

Read More >
↓